Member Info for Porky9

Just take a look at Perkin Elmer Results just out:-
https://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-announces-financial-results-first-quarter-2021

AND more over look at the forward earnings.
IMO Novacyt will have a very strong 2021 year, Certainly Q1 is already solid and I have every confidence that any lost DHSC business will be made up a) under the framework deal and b) from other deals/markets.

Very positive outlook

I haven't yet seen any of the filming carried out in the care homes and that was weeks ago now.
Sounds like a blockbuster of a release due...

@Harchris
Also taken from the R&D update:-
"Novacyt has launched a CE-IVD genesig® COVID-19 three-gene target test for use with nasopharyngeal, oropharyngeal and saliva sample types. This key extension to the genesig® COVID-19 portfolio, alongside the one-gene and two-gene tests, is expected to be critical for use in airport test and release programmes to and from certain countries"

Will they secure much business from international airports outside of the UK?

Remaining Confident

My tweet in relation to the return to travel:-
https://twitter.com/Porky9Here/status/1389638754730749959

Government ironing out traffic light system but a requirement to PCR test at day 2 and 8 after return looking likely.

Control against VOCs is going to be essential going forwards to ensure we don't get a further set back

GLA

Compliments of New Forms Research on Twitter:-
https://twitter.com/NewFormsResearc/status/1389618313358106629

Novacyt are actively involved with the program!!

Another Q? Panels view on how diagnostics industry & world leaders planning to collectively tackle COVID-19?
ACTAccelerator raised initial target of "500 million diagnostic tests in 2021 by 400 million tests, leading to a total of 900 million tests over a period of 12 months"

The key take here is that we are not just involved in these programs but we are sitting at top table against major peers in the diagnostics space. This really is a big deal and such a great thing to be involved with.

Mind you the entire market is down and i thought the press was telling us Covid was over this morning...

Yes, we only lost nearly £20m off our already pathetically low market cap today.

I would like to see this as a main market listing duel with a Nasdaq listing OR Just a Nasdaq listing on its own

1) Quarterly Reporting
2) ONE language
3) Massive Investor reach beyond anything we can dream of in our current format

If they want to increase the shares in issue, with a share split to facilitate increased liquidity i would fully support that also.

something has to give

Pork's

Lol, not on ball this am, message from car, Luck to complete trade reception shocking

Sold out another holding at small profit
Added £26k at 4.46 (2 deals)
I consider this stock offers possibly the best upside potential in the market from this level
Great kind jesture from company this am btw
Good Luck whatever your call

Feeling very Positive going into this week following the UK bank holiday.

Unless a news update lands, I'm expecting the open to be slightly down based on the small minus in France yesterday however, i think this is about to materially change and I'm just going t buy into this as funds permit.

Risk ratio now for further lows V update and sharp spike north are rapidly increasing. If i was short i would be getting ahead now and closing.

Time will tell, good luck all

Pork's

I would love us to come off this French market but i can't see it due to the French connections.

Just hope that they can fully evaluate and see that the business has completely outgrown the Bourse. It needs to be on a main market listing at least or ideally for me a complete move to the Nasdaq where it can attract a correct rating and be supported by investors that a) understand the diagnostics sector and b) have a significantly bigger reach.

Not to mention having to issue everything in two bloody languages, like the rest rest of the world give a stuff about reading anything in French!!!. I wouldn't mind if we actually got orders from France but its next to sod all, even the appointed French brokers are a Joke. ODDO?? what's the point of them - sack them i say!!! Anyhow, have to live with it for now.

Interesting that Roche are on the talk Friday... Its great that Novacyt are at the Top table, just need our SP to catch up now.

Despite the nonsense in France i still feel we are in for a better week, so many things building behind the scenes, cream always rises to the top, just need to maintain the patience as frustrating as that may be at times...

GLA

The EXACT figure was 1.28% at close on Friday:-
896,000 shares were short on Friday that will need to be brought back

Don't know what todays position is

1.2% on Friday - Dont know what it is today yet

Send Answers on a postcard only

The previous shorting attack was in France
Our market is closed so nothing we can do
Any short stock has to be brought back but it encourages sell off of remaining retail
Communication also big issue - have they a real clue what the business is even doing. French broker is clearly a waste of time

Discussed this last week but it remains VERY significant:-

We only have 70 million shares in issue, circa 12% in II hands, 88% in Retail hands, 1.2% short
Shares split over two trading markets

As a result, positive news and even the smallest of run on this stock would see the share Price move up significantly. This is a VERY small number of shares in issue.

If NCYT would move to the Nasdaq and i intend to raise this at the AGM, this has been put to the company previously, it would open the door to a significant reach of investors, a market many multiples the size of the crappy French exchange we are currently listed on and the AIM put together. Not to mention ditching having to do everything in duplicate French and English.

Also if you look at our larger peers such as Thermo Fisher they have 393m shares in issue.

I would be absolutely delighted if they did move to the Nasdaq and even if they did a 5 for 1 listing and increased shares in issue to 350m to create better liquidity

@CSDI1962
Indeed we should all remain positive
There are so many amazing things going on here and the R&D update lets face it was world class...

Business side is building at a fantastic rate, this really is history in the making. They have all bases covered and an incredible worldwide partner and distribution network established.

Many investors overlook this fact but once you have this level of infrastructure in place, proven with multi million value sales going through it, the moment they acquire a business or product or plain develop a new product from scratch once its ready, it can be added instantly to this existing route to market. I can tell you this is significant. It is materially different to say a lab releasing a new product which is all singing and dancing but without an established route to market it can take years to gain traction. Novacyt don't have that issue.

The Share Price is on its ars@ so to speak, but the business isn't and this is why I'm relaxed about my investment here and continue to build on it. I have a paper loss at the moment but as I'm not in any hurry to sell and confident of the future. The SP will catch up with its fundamentals, just a matter of time. I realise we live in an instant world but time is all we need here and we are fairly close to VERY big things imo.

Finally a move to mid market or the Nasdaq would make a material difference to the share price and i hope that does become a reality but until then ultimately the Share Price will be re-valued anyhow.

Onwards and upwards, GLA

Pork's

@Hillseeker
Totally agree, a really well written, quality heart felt post. We are with you all the way.
Onwards and Upwards
Thanks

Due an acquisition, Due news on DHSC dispute, Due confirmation on Stateside position

Accounts, product updates, H1 we are now entering a news rich period

Its fantastic that shortly Novacyt will have all bases covered.

GLA